The Involvement of PGRMC1 Signaling in Cognitive Impairment Induced by Long-Term Clozapine Treatment in Rats

Olanzapine-induced nonalcoholic fatty liver disease: The effects of differential food pattern and the involvement of PGRMC1 signaling

(2023) ZhenYu Zhu et al.   FOOD AND CHEMICAL TOXICOLOGY

Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives

(2022) Shimeng Jiao et al.   Frontiers in Pharmacology

Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein

(2021) Colleen S. Limegrover et al.   JOURNAL OF NEUROSCIENCE RESEARCH

A Potential Mechanism Underlying the Therapeutic Effects of Progesterone and Allopregnanolone on Ketamine-Induced Cognitive Deficits

(2021) Ting Cao et al.   Frontiers in Pharmacology

Clozapine Induced Disturbances in Hepatic Glucose Metabolism: The Potential Role of PGRMC1 Signaling

(2021) Ting Cao et al.   Frontiers in Endocrinology

Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling

(2020) Diego A. Pedroza et al.   BRITISH JOURNAL OF CANCER

The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates

(2020) Aladdin Riad et al.   MOLECULAR NEUROBIOLOGY

Proceedings from the Fourth International Symposium on sigma-2 Receptors: Role in Health and Disease

(2020) Nicholas J. Izzo et al.   eNeuro

Early enriched environment prevents cognitive impairment in in an animal model of schizophrenia induced by MK-801: Role of hippocampal BDNF

(2019) Mahdiyeh Faatehi et al.   BRAIN RESEARCH

Predictors of treatment resistant schizophrenia: a systematic review of prospective observational studies

(2019) S. E. Smart et al.   PSYCHOLOGICAL MEDICINE

Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation

(2019) Leila Haery et al.   Frontiers in Neuroanatomy

Mifepristone as a Psychopharmacologic Agent: Consideration of Efficacy, Plasma Levels, and Mechanism of Action

(2018) Julia A. Golier et al.   BIOLOGICAL PSYCHIATRY

More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose–response and comparison to AAV PHP.B

(2018) Robert D. Dayton et al.   GENE THERAPY

Cognitive effects of mifepristone in overweight, euthymic adults with depressive disorders

(2018) S. Roat-Shumway et al.   JOURNAL OF AFFECTIVE DISORDERS

Down-regulation of Long Noncoding RNA MALAT1 Protects Hippocampal Neurons Against Excessive Autophagy and Apoptosis via the PI3K/Akt Signaling Pathway in Rats with Epilepsy

(2018) Qiang Wu et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Liraglutide prevents metabolic side-effects and improves recognition and working memory during antipsychotic treatment in rats

(2018) Ilijana Babic et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats

(2018) Zhiyi Xie et al.   NEUROPHARMACOLOGY

Let-7i inhibition enhances progesterone-induced functional recovery in a mouse model of ischemia

(2018) Trinh Nguyen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Maternal Cognitive Impairment Associated with Gestational Diabetes Mellitus—A Review of Potential Contributing Mechanisms

(2018) Cini John et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Space, time, and episodic memory: The hippocampus is all over the cognitive map

(2017) Arne D. Ekstrom et al.   HIPPOCAMPUS

Clozapine blockade of MK-801-induced learning/memory impairment in the mEPM: Role of 5-HT 1A receptors and hippocampal BDNF levels

(2017) Ximena López Hill et al.   PHYSIOLOGY & BEHAVIOR

Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha

(2017) Chen Zhang et al.   PSYCHONEUROENDOCRINOLOGY

Pgrmc1/BDNF Signaling Plays a Critical Role in Mediating Glia-Neuron Cross Talk

(2016) Fen Sun et al.   ENDOCRINOLOGY

Baicalin Attenuates Ketamine-Induced Neurotoxicity in the Developing Rats: Involvement of PI3K/Akt and CREB/BDNF/Bcl-2 Pathways

(2016) Daiying Zuo et al.   NEUROTOXICITY RESEARCH

Neural effects of gut- and brain-derived glucagon-like peptide-1 and its receptor agonist

(2016) Kenichi Katsurada et al.   Journal of Diabetes Investigation

Measure of anxiety-related behaviors and hippocampal BDNF levels associated to the amnesic effect induced by MK-801 evaluated in the modified elevated plus-maze in rats

(2015) Ximena López Hill et al.   PHYSIOLOGY & BEHAVIOR

A potential mechanism underlying atypical antipsychotics-induced lipid disturbances

(2015) H L Cai et al.   Translational Psychiatry

Progesterone Receptor Membrane Component 1 Is a Functional Part of the Glucagon-like Peptide-1 (GLP-1) Receptor Complex in Pancreatic β Cells

(2014) Ming Zhang et al.   MOLECULAR & CELLULAR PROTEOMICS

Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar–Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder

(2012) Sarah Mc Fie et al.   BRAIN RESEARCH

Progesterone Increases the Release of Brain-Derived Neurotrophic Factor from Glia via Progesterone Receptor Membrane Component 1 (Pgrmc1)-Dependent ERK5 Signaling

(2012) Chang Su et al.   ENDOCRINOLOGY

The effects of imperatorin on anxiety and memory-related behavior in male Swiss mice.

(2012) Barbara Budzynska et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Age dependent learning and memory deficit in Pentylenetetrazol kindled mice

(2011) Awanish Mishra et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Pharmacotherapy for treatment-refractory schizophrenia

(2011) Scott P Van Sant et al.   EXPERT OPINION ON PHARMACOTHERAPY

Nicotine Improves Working Memory Span Capacity in Rats Following Sub-Chronic Ketamine Exposure

(2011) Samantha L Rushforth et al.   NEUROPSYCHOPHARMACOLOGY

Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site

(2011) Jinbin Xu et al.   Nature Communications

Adenosine A1 receptor-mediated transactivation of the EGF receptor produces a neuroprotective effect on cortical neurons in vitro

(2009) Ke-qiang Xie et al.   ACTA PHARMACOLOGICA SINICA

Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease

(2009) Talib Abbas et al.   BEHAVIOURAL BRAIN RESEARCH

Progesterone Increases Rat Neural Progenitor Cell Cycle Gene Expression and Proliferation Via Extracellularly Regulated Kinase and Progesterone Receptor Membrane Components 1 and 2

(2009) Lifei Liu et al.   ENDOCRINOLOGY

PGRMC1 (progesterone receptor membrane component 1): A targetable protein with multiple functions in steroid signaling, P450 activation and drug binding

(2008) Hannah J. Rohe et al.   PHARMACOLOGY & THERAPEUTICS

Clozapine and olanzapine exhibit an intrinsic anxiolytic property in two conditioned fear paradigms: Contrast with haloperidol and chlordiazepoxide

(2008) A MEAD et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

The membrane-associated progesterone-binding protein 25-Dx: Expression, cellular localization and up-regulation after brain and spinal cord injuries

(2007) R. Guennoun et al.   BRAIN RESEARCH REVIEWS